Benign neoplasm: Urethra

CD2_BENIGN_URETHRA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D30.4& Hospital discharge: ICD-9 — 2232 Cause of death: ICD-10 — D30.4& Cause of death: ICD-9 — 2232 2 out of 7 registries used, show all original rules.	46
4. Check minimum number of events None	46
5. Include endpoints None	46
6. Filter based on genotype QC (FinnGen only)	46

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D30
Name in latin: Neoplasma benignum urethrae

NAME	CD2_BENIGN_URETHRA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D304
HD_ICD_9	2232
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D304
COD_ICD_9	2232
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Urethra based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Urethra

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	293	179	112
Only index persons	256	159	97
Unadjusted period prevalence (%)
Whole population	0.00	0.01	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	58.14	60.68	54.31
Only index persons	56.69	58.96	52.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	46	29	17
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	60.55	59.01	63.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3049717) Cytology report of Urine Cyto stain

9.32

7.92

3.8

1.5

—

(40761535) Cells panel - Urine sediment

4.50

3.91

3.7

4.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

8.40

3.15

1.5

2.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

253

3.36

3.06

8.6

4.6

—

485.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

261

2.74

2.12

7.1

4.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

148

2.30

1.99

4.5

3.1

—

(3035350) Ketones [Presence] in Urine by Test strip

188

2.25

1.86

4.3

3.6

0.0

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3.25

1.80

2.1

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.69

1.74

9.5

7.0

—

(3029937) Albumin [Presence] in Urine by Test strip

2.22

1.68

5.4

4.1

0.0

estimate

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.99

1.65

2.6

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

189

2.04

1.50

4.7

5.1

0.0

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

143

2.03

1.49

4.4

3.9

—

(3045414) Leukocytes [Presence] in Urine

3.37

1.48

1.8

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

171

2.01

1.47

8.2

5.7

1.2

mmol/l

0.57

155

(3009261) Glucose [Presence] in Urine by Test strip

190

2.02

1.46

4.3

3.6

0.0

estimate

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

182

1.99

1.42

5.2

3.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.07

1.36

2.9

3.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

185

1.93

1.32

8.0

6.9

1.2

mmol/l

0.10

157

(3015736) pH of Urine

149

1.91

1.29

3.6

—

(3048689) Calprotectin [Mass/mass] in Stool

2.33

1.26

2.8

1.7

100.9

208.7

ug/g

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

209

1.87

1.19

5.1

7.4

10.4

10.1

umol/l

0.10

196

(3002256) Pathology report gross observation

2.13

1.10

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2.04

1.06

2.0

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.05

0.99

1.9

1.6

—

(3026008) Bacteria identified in Urine by Culture

132

1.75

0.97

5.5

3.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.22

0.93

1.7

—

(1761868) Lipid panel - Serum or Plasma

143

0.54

0.89

2.7

3.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.80

0.84

10.8

5.5

1.1

1.0

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.87

0.82

1.3

—

(40768804) Tissue Pathology biopsy report

149

1.61

0.76

2.6

2.0

—

(3042936) Bacteria identified in Isolate by Culture

1.82

0.76

1.7

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.68

0.75

1.6

2.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.78

0.72

1.4

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.74

0.70

1.4

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

1.88

0.68

1.4

3.7

47.6

75.3

e9/l

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

0.62

0.0

3.4

—

0.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.00

0.61

0.0

5.1

—

25.6

—

(3019225) pH of Specimen

1.76

0.59

6.2

5.9

—

(3019060) Gas panel - Arterial blood

1.76

0.59

4.0

3.2

—

(3022145) Colonoscopy Study observation

1.66

0.57

1.5

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

378

1.78

0.51

5.6

4.6

5.6

5.9

mmol/l

1.40

350

(36304419) Bacteria [Presence] in Urine

113

1.49

0.51

4.4

2.7

—

(3023368) Bacteria identified in Blood by Culture

113

1.49

0.51

3.9

4.7

—

(42870588) Differential panel, method unspecified - Blood

123

1.46

0.49

2.1

6.4

—

(3002385) Erythrocyte distribution width [Ratio]

318

0.69

0.49

27.7

19.5

13.5

13.7

0.25

311

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.47

0.46

6.9

5.8

2.6

2.1

ug/l

0.27

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

163

1.40

0.45

2.6

4.3

16.8

61.2

ng/l

1.03

116

(3044640) Blood type and Crossmatch panel - Blood

116

1.43

0.44

2.1

2.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.42

0.0

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.42

0.0

4.0

—

48.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.53

0.42

5.0

4.2

1.3

1.2

mmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.41

0.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

0.41

0.0

3.4

—

0.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.35

0.34

1.3

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

133

1.31

0.29

4.9

3.1

29.1

502.7

e6/l

0.48

102

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

387

1.55

0.28

19.0

15.7

29.7

23.1

mg/l

0.37

304

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.25

0.27

2.9

3.3

2.5

mmol/l

—

(3030467) Casts [#/volume] in Urine by Automated count

116

1.30

0.26

4.6

2.9

0.1

0.4

e6/l

0.94

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.33

0.25

2.2

2.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.74

0.25

7.1

4.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

295

1.28

0.25

5.1

4.2

15.3

15.0

pmol/l

0.19

263

(3019150) Specific gravity of Urine by Refractometry

1.34

0.25

3.6

—

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

10.8

—

(3008898) HLA-B27 [Presence]

0.00

0.21

0.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.21

0.0

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.7

—

19.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

3.3

—

5.1

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.00

0.21

0.0

1.0

—

0.9

—

(3012501) Base excess in Blood by calculation

0.00

0.21

0.0

3.3

—

2.4

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

3.3

—

7.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

47.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.21

0.0

6.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.23

0.21

1.0

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.20

0.0

1.6

—

3.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

0.3

—

(40758558) Short blood count panel - Blood

1.27

0.20

2.3

7.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.27

0.19

1.0

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

330

1.25

0.19

21.4

16.7

39.7

40.3

0.22

232

(3019550) Sodium [Moles/volume] in Serum or Plasma

399

0.85

0.18

22.6

17.7

139.0

139.6

mmol/l

0.70

387

(3023103) Potassium [Moles/volume] in Serum or Plasma

398

0.87

0.18

22.9

17.8

4.0

mmol/l

0.99

387

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1.15

0.18

4.3

3.4

0.6

0.7

ug/l

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

0.77

0.17

4.2

3.1

24.5

97.5

ng/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

367

0.81

0.16

15.3

15.5

74.4

77.7

ml/min/173m2

0.42

297

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

360

1.14

0.07

6.5

5.4

37.6

40.0

mmol/mol

1.84

336

(3041096) Erythrocytes [Presence] in Urine by Automated

110

1.12

0.05

5.3

3.4

—

(3044889) 12 lead EKG panel

260

0.92

0.05

5.1

3.7

—

(3003694) ABO and Rh group [Type] in Blood

103

1.09

0.02

1.2

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

157

0.93

0.02

2.9

2.0

82.5

99.2

pmol/l

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

113

0.97

0.00

5.8

3.4

29.7

28.3

u/l

0.17

104

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

204

0.97

0.00

3.1

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.02

0.00

1.6

1.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.0

2.9

—

1.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

3.5

—

57.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.0

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3016879) Cocaine [Presence] in Urine

0.00

0.0

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

5.5

—

65.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

0.91

0.00

3.2

2.3

13.6

13.7

umol/l

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.0

1.7

—

187.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(4094501)

0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

4.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

0.00

0.0

4.6

—

0.9

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(4306422)

0.00

0.0

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

4.1

—

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.4

—

196.5

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.0

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

2.0

—

1451.4

—

(3021788) Differential panel - Synovial fluid

0.00

0.0

1.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

1.8

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.5

—

111.8

—

(3013512) EKG study

120

1.00

0.00

3.7

4.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

2.0

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.0

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.4

—

105.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.7

—

(3027008) Opiates [Presence] in Urine

0.00

0.0

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

4.1

—

6.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

355.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

4.3

—

3.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1616796) Gas panel - Central venous blood

0.00

0.0

2.5

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.0

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

4.3

—

106.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.0

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

3.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.3

—

206.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3016038) Potassium [Moles/volume] in Urine

0.00

0.0

1.0

—

32.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

0.00

0.0

23.3

—

6.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.8

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.4

—

(3012441) Differential panel - Pleural fluid

0.00

0.0

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

3.0

—

6.5

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.4

—

44.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_URETHRA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_URETHRA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_URETHRA – Benign neoplasm: Urethra

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Urethra

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints